The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Accolade Revenue

The IBN SINA Pharmaceutical Industry had revenue of 2.88B BDT in the quarter ending March 31, 2025, with 12.89% growth. This brings the company's revenue in the last twelve months to 11.80B, up 8.63% year-over-year. In the fiscal year ending June 30, 2024, The IBN SINA Pharmaceutical Industry had annual revenue of 11.37B with 24.61% growth.

• Revenue (ttm): 11.80B
• Revenue Growth: +8.63%
• P/S Ratio: 0.83
• Revenue / Employee: 2.81M
• Employees: 4,200
• Market Cap: 9.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	11.37B	2.25B	24.61%
Jun 30, 2023	9.13B	645.51M	7.61%
Jun 30, 2022	8.48B	1.10B	14.96%
Jun 30, 2021	7.38B	1.18B	19.13%
Jun 30, 2020	6.19B	927.67M	17.62%